THC Therapeutics (THCT) said it has acquired The Headquarters Group (THG) in an all-share transaction valued at approximately $11 million.
THG is a holding company with a portfolio of companies in genetics, cultivation, extraction, and distribution as well specialty real estate and nutrients for commercial and hobby cannabis growers. THCT and the current operators of THG will assume control of management.
“This collaboration of deep expertise from world class cannabis operations management with over 60 years of combined experience will allow us to maximize efficiencies and generate significant revenue for THCT. The combined Company will serve as a vertically integrated foundation in the Company’s focused roll-up strategy to acquire industry leading cannabis companies in the cultivation, manufacturing, distribution and nutrients segments within the regulated cannabis industry,” said THCT CEO Scott Cox.
With the acquisition, THCT has expanded in California and Oregon with the potential to grow established operations and brands and expand these brands into other U.S. and international legal markets.
